Key Collaboration Between World Medicine and Bio-Thera

World Medicine and Bio-Thera signed an Exclusive License and Commercialization Agreement for Ustekinumab.

World Medicine, Türkiye’s pharmaceutical export champion, which continues its efforts with the goal of delivering accessible and effective products worldwide, has entered into an important collaboration with Bio-Thera Solutions, a China-based biopharmaceutical company developing innovative therapies and biosimilars, by signing an exclusive license and commercialization agreement. Under this agreement, World Medicine will introduce to the Turkish market a Ustekinumab-based medicine manufactured in China and used in the treatment of Crohn’s disease.

Through its collaboration agreement with Bio-Thera Solutions, World Medicine aims to improve patients’ quality of life by offering more advanced solutions for the treatment of many autoimmune diseases, particularly Crohn’s disease. While Bio-Thera will manufacture the Ustekinumab-based medicine at its facilities in Guangzhou, China, in compliance with GMP standards, World Medicine will hold the marketing authorization for the medicine in Türkiye and will undertake its promotion and sales under the agreement.

Through this strategic collaboration, World Medicine aims to make more advanced and effective treatment options available in Türkiye for diseases such as ulcerative colitis, plaque psoriasis, and psoriatic arthritis, while also offering a new treatment option for adult patients with autoimmune conditions such as moderate to severe Crohn’s disease who do not respond to conventional therapies, cannot tolerate such therapies, or have contraindications to them.

Ruşen Kalender, Chairman of the Board of Directors of World Medicine, stated that with this important partnership they aim to provide effective treatment options of high medical quality: “As World Medicine, we have worked from day one to improve people’s quality of life through our broad product portfolio. Our partnership with Bio-Thera Solutions is a natural outcome of this objective. Through this collaboration, we have taken an important step toward bringing a highly significant treatment such as Ustekinumab to patients in the Turkish market by offering sustainable solutions in healthcare.”

Dr. Shengfeng Li, CEO of Bio-Thera, said: “At Bio-Thera, we are very pleased to partner with World Medicine to commercialize our Ustekinumab biosimilar in Türkiye. We are excited to work with World Medicine to bring this important biosimilar medicine to patients in Türkiye.”

About World Medicine

Operating in Türkiye since 2011, World Medicine İlaç Sanayi ve Ticaret Anonim Şirketi is committed to improving quality of life by offering accessible and effective products worldwide through an innovative perspective and in line with sustainable quality standards. Aiming to be a reliable business partner and a leading company in all countries and fields in which it operates, World Medicine continues its activities with a broad portfolio of more than 600 pharmacological products across medical fields including ophthalmology, neurology, endocrinology, cardiology, rheumatology, gastroenterology, urology, and respiratory diseases. Exporting pharmaceuticals to more than 50 countries, World Medicine aims to make Türkiye its main manufacturing and hub center through its investments.

For more information, please visit www.worldmedicine.com.tr and follow its social media accounts on X (@worldmedicinetr), LinkedIn (in/worldmedicineturkiye), and Instagram (@worldmedicineturkiye).

About Bio-Thera Solutions

Bio-Thera Solutions, Ltd. is an innovative global biopharmaceutical company based in Guangzhou, China. The company conducts research and development of new therapeutics for cancer, autoimmune diseases, cardiovascular diseases, ophthalmic diseases, and other serious medical needs. It also develops biosimilars of existing biologic drugs for the treatment of various cancers and autoimmune diseases.

For more information, please visit www.bio-thera.com/en/ and follow its social media accounts on X (@bio_thera_sol), LinkedIn (in/bio-thera-solutions-ltd), and WeChat (Bio-Thera).

IMPORTANT! In order to understand how users visit our website, our Website uses cookies and other similar tools. By clicking Accept All, you agree to the storage of cookies on your device so we can improve site navigation, measure site performance and show you personalized ads. You can personalize your consent in the Cookie Settings section. For more detailed information about cookies, You can personalize your consent in the Cookie Settings section.

Settings Reject All Accept All
Close
Settings

These cookies are necessary to ensure the functioning of our website and cannot be switched off in our systems. They are usually only set in response to actions taken by yourself which involve a request for services, such as setting your privacy preferences, logging in or filling in forms. You may set your browser to block or alert you to these cookies, but the functions and services will not work without these cookies and it would then not be possible to save your preferences regarding cookies. These cookies do not store any personally identifiable information.

These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. It measures how often you visit our site and how you use it. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.

These cookies may be placed through our website by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant ads on other sites. These cookies collect personal information by uniquely identifying your browser and internet device to determine your interests. If you do not allow these cookies, you will experience less targeted advertising. These cookies, which are stored on your device by the third parties listed below subject to your prior consent, allow us to count the number of times the ad content was viewed in our ad slots and to determine this content, the number of views for each of page, the number of users who click on each page and any other actions taken by users on sites linked to this advertising content, in order to be able to calculate totals and generate statistics due to the actors in the advertising distribution chain (communication agencies, advertising management, site/distribution environment).